Abstract GMM-051: A CLIA-CERTIFIED HIGH-THROUGHPUT DRUG SCREENING PLATFORM FOR OVARIAN CANCER TO INFORM PERSONALIZED CANCER CARE AND DISCOVER NOVEL COMBINATIONSFranz X. Schaub, Carla Grandori, Michael Churchill et al.|Clinical Cancer Research|2019Cited by 0